Vanguard Clinical Research has begun conducting trials an oral medication to relieve symptoms for people with a mild to moderate infection. “The research has been approved for 100 patients. Those are people who either think they have COVID-19, for which they’ll be tested, or they may have a common cold,” said Dr. Alan Tannenbaum, medical director of the clinical research team at Vanguard Clinical Research. In addition to helping clinical trials at facilities, Yourway is helping to lead the charge toward a more patient-centric supply chain by offering direct-to-patient services.